← FDA Drug Approvals (Drugs@FDA)
LOTEPREDNOL ETABONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PADAGIS US · Approved 2024-07-10
Drug application
- FDA Application #
ANDA215203- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LOTEPREDNOL ETABONATE
- Generic name
- LOTEPREDNOL ETABONATE
- Active ingredients
- LOTEPREDNOL ETABONATE
- Dosage form
- SUSPENSION/DROPS
- Route
- OPHTHALMIC
- Marketing status
- Prescription
- Sponsor
- PADAGIS US
- Manufacturer
- Padagis US LLC
- First approval
- 2024-07-10
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown